Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.570
+0.060 (2.39%)
At close: Jan 17, 2025, 4:00 PM
2.550
-0.020 (-0.78%)
After-hours: Jan 17, 2025, 7:49 PM EST
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $274.96 million as of January 17, 2025. Its market cap has increased by 246.73% in one year.
Market Cap
274.96M
Enterprise Value
103.76M
1-Year Change
246.73%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $274.96M, an increase of 28.18%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 183.60M | 3.67% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |